Magnetic resonance colonography in rats with TNBS-induced colitis: A feasibility and validation study

Inflammatory Bowel Diseases

Volumn 18, Issue 10, 2012, Pages 1940-1949

  Charpentier, Cloé ^a,b   Marion Letellier, Rachel ^a   Savoye, Guillaume ^a,b   Nicol, Lionel ^a   Mulder, Paul ^a   Aziz, Moutaz ^b   Vera, Pierre ^a   Déchelotte, Pierre ^a,b   Savoye Collet, Céline ^a,b  

^a UNIVERSITÉ DE ROUEN   (France)

^b ROUEN UNIVERSITY HOSPITAL   (France)

Author keywords

colitis imaging; magnetic resonance colonography; TNBS colitis

Indexed keywords

BIOLOGICAL MARKER; GADOLINIUM; TRINITROBENZENESULFONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFACT; COLITIS; COLON HEIGHT; COLON WEIGHT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DRUG SCREENING; ENTERITIS; FEASIBILITY STUDY; HISTOPATHOLOGY; IMAGE QUALITY; MAGNETIC RESONANCE COLONOGRAPHY; MALE; MEASUREMENT; MEDIATOR RELEASE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; SCORING SYSTEM; SIGNAL TRANSDUCTION; STOMACH MUCOSA; VALIDATION STUDY;

ANIMALS; BLOTTING, WESTERN; COLITIS; COLONOSCOPY; CYCLOOXYGENASE 2; CYTOKINES; DISEASE MODELS, ANIMAL; FEASIBILITY STUDIES; INFLAMMATION MEDIATORS; INTESTINAL MUCOSA; MAGNETIC RESONANCE IMAGING; MALE; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCIBILITY OF RESULTS; TRINITROBENZENESULFONIC ACID;

EID: 84866354223     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.22897     Document Type: Article

References (36)

1. Podolsky DK,. Inflammatory bowel disease. N Engl J Med. 2002; 347: 417-429. (Pubitemid 34851835)
2. Baert F, Moortgat L, Van Assche G, et al. Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease. Gastroenterology. 2010; 138: 463-468; quiz e410-461.
3. D'Haens GR, Fedorak R, Lémann M, et al. Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohn's disease. Inflamm Bowel Dis. 2009; 15: 1599-1604.
4. Ko CW, Dominitz JA,. Complications of colonoscopy: magnitude and management. Gastrointest Endosc Clin N Am. 2010; 20: 659-671.
5. Gupta M, Holub JL, Eisen G,. Do indication and demographics for colonoscopy affect completion? A large national database evaluation. Eur J Gastroenterol Hepatol. 2010; 22: 620-627.
6. Shoenut JP, Semelka RC, Magro CM, et al. Comparison of magnetic resonance imaging and endoscopy in distinguishing the type and severity of inflammatory bowel disease. J Clin Gastroenterol. 1994; 19: 31-35. (Pubitemid 24222237)
7. Kettritz U, Isaacs K, Warshauer DM, et al. Crohn's disease. Pilot study comparing MRI of the abdomen with clinical evaluation. J Clin Gastroenterol. 1995; 21: 249-253.
8. Gotthardt M, Bleeker-Rovers CP, Boerman OC, et al. Imaging of inflammation by PET, conventional scintigraphy, and other imaging techniques. J Nucl Med. 2010; 51: 1937-1949.
9. Desmond AN, O'Regan K, Curran C, et al. Crohn's disease: factors associated with exposure to high levels of diagnostic radiation. Gut. 2008; 57: 1524-1529.
10. Molinie F, Gower-Rousseau C, Yzet T, et al. Opposite evolution in incidence of Crohn's disease and ulcerative colitis in northern France (1988-1999). Gut. 2004; 53: 843-848. (Pubitemid 38662134)
11. Maccioni F, Viscido A, Broglia L, et al. Evaluation of Crohn disease activity with magnetic resonance imaging. Abdom Imaging. 2000; 25: 219-228. (Pubitemid 30304973)
12. Koh DM, Miao Y, Chinn RJS, et al. MR imaging evaluation of the activity of Crohn's disease. Am J Roentgenol. 2001; 177: 1325-1332. (Pubitemid 33081474)
13. Horsthuis K, Stokkers PC, Stoker J,. Detection of inflammatory bowel disease: diagnostic performance of cross-sectional imaging modalities. Abdom Imaging. 2008; 33: 407-416. (Pubitemid 351713074)
14. Rimola J, Rodriguez S, Garcia-Bosch O, et al. Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn's disease. Gut. 2009; 58: 1113-1120.
15. Rimola J, Ordás I, Rodriguez S, et al. Magnetic resonance imaging for evaluation of Crohn's disease: Validation of parameters of severity and quantitative index of activity. Inflamm Bowel Dis. 2011; 17: 1759-1768.
16. Ordas I, Rimola J, Ripolles T, et al. Accuracy of MRI to assess therapeutic responses and mucosal healing in Crohn's disease. Gastroenterology. 2011; 140: S-73.
17. Morris GP, Beck PL, Herridge MS, et al. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology. 1989; 96: 795-803. (Pubitemid 19057602)
18. Palmen MJ, Dieleman LA, van der Ende MB, et al. Non-lymphoid and lymphoid cells in acute, chronic and relapsing experimental colitis. Clin Exp Immunol. 1995; 99: 226-232.
19. Larsson AE, Melgar S, Rehnstrom E, et al. Magnetic resonance imaging of experimental mouse colitis and association with inflammatory activity. Inflamm Bowel Dis. 2006; 12: 478-485.
20. Melgar S, Gillberg P-G, Hockings PD, et al. High-throughput magnetic resonance imaging in murine colonic inflammation. Biochem Biophys Res Commun. 2007; 355: 1102-1107. (Pubitemid 46366941)
21. Mustafi D, Fan X, Dougherty U, et al. High-resolution magnetic resonance colonography and dynamic contrast-enhanced magnetic resonance imaging in a murine model of colitis. Magn Reson Med. 2010; 63: 922-929.
22. Frericks BB, Wacker F, Loddenkemper C, et al. Magnetic resonance imaging of experimental inflammatory bowel disease: quantitative and qualitative analyses with histopathologic correlation in a rat model using the ultrasmall iron oxide SHU 555 C. Invest Radiol. 2009; 44: 23-30.
23. Pohlmann A, Tilling LC, Robinson A, et al. Progression and variability of TNBS colitis-associated inflammation in rats assessed by contrast-enhanced and T2-weighted MRI. Inflamm Bowel Dis. 2009; 15: 534-545.
24. Hassan A, Ibrahim A, Mbodji K, et al. An alpha-linolenic acid-rich formula reduces oxidative stress and inflammation by regulating NF-kappaB in rats with TNBS-induced colitis. J Nutr. 2010; 140: 1714-1721.
25. Ibrahim A, Mbodji K, Hassan A, et al. Anti-inflammatory and anti-angiogenic effect of long chain n-3 polyunsaturated fatty acids in intestinal microvascular endothelium. Clin Nutr. 2011; 30: 678-687.
26. Ahualli J,. The target sign: bowel wall. Radiology. 2005; 234: 549-550. (Pubitemid 40139928)
27. Kretzmann NA, Fillmann H, Mauriz JL, et al. Effects of glutamine on proinflammatory gene expression and activation of nuclear factor kappa B and signal transducers and activators of transcription in TNBS-induced colitis. Inflamm Bowel Dis. 2008; 14: 1504-1513.
28. Camacho-Barquero L, Villegas I, Sánchez-Calvo JM, et al. Curcumin, a Curcuma longa constituent, acts on MAPK p38 pathway modulating COX-2 and iNOS expression in chronic experimental colitis. Int Immunopharmacol. 2007; 7: 333-342. (Pubitemid 46186172)
29. Rimola J, Rodriguez S, Garcia-Bosch O, et al. Role of 3.0-T MR colonography in the evaluation of inflammatory bowel disease. Radiographics. 2009; 29: 701-719.
30. Schreyer AG, Rath HC, Kikinis R, et al. Comparison of magnetic resonance imaging colonography with conventional colonoscopy for the assessment of intestinal inflammation in patients with inflammatory bowel disease: a feasibility study. Gut. 2005; 54: 250-256. (Pubitemid 40139242)
31. Marcos HB, Semelka RC,. Evaluation of Crohn's disease using half-Fourier RARE and gadolinium-enhanced SGE sequences: initial results. Magn Reson Imaging. 2000; 18: 263-268. (Pubitemid 30220702)
32. Gourtsoyiannis N, Papanikolaou N, Grammatikakis J, et al. Assessment of Crohn's disease activity in the small bowel with MR and conventional enteroclysis: preliminary results. Eur Radiol. 2004; 14: 1017-1024. (Pubitemid 38787247)
33. Haggett PJ, Moore NR, Shearman JD, et al. Pelvic and perineal complications of Crohn's disease: assessment using magnetic resonance imaging. Gut. 1995; 36: 407-410.
34. Knollmann FD, Dietrich T, Bleckmann T, et al. Magnetic resonance imaging of inflammatory bowel disease: evaluation in a rabbit model. J Magn Reson Imaging. 2002; 15: 165-173. (Pubitemid 34112906)
35. Oto A, Zhu F, Kulkarni K, et al. Evaluation of diffusion-weighted MR imaging for detection of bowel inflammation in patients with Crohn's disease. Acad Radiol. 2009; 16: 597-603.
36. Oussalah A, Laurent V, Bruot O, et al. Diffusion-weighted magnetic resonance without bowel preparation for detecting colonic inflammation in inflammatory bowel disease. Gut. 2010; 59: 1056-1065.